Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.
Wiessing L, Ferri M, Běláčková V, Carrieri P, Friedman SR, Folch C, Dolan K, Galvin B, Vickerman P, Lazarus JV, Mravčík V, Kretzschmar M, Sypsa V, Sarasa-Renedo A, Uusküla A, Paraskevis D, Mendão L, Rossi D, van Gelder N, Mitcheson L, Paoli L, Gomez CD, Milhet M, Dascalu N, Knight J, Hay G, Kalamara E, Simon R; EUBEST working group; Comiskey C, Rossi C, Griffiths P. Wiessing L, et al. Among authors: lazarus jv. Harm Reduct J. 2017 Apr 22;14(1):19. doi: 10.1186/s12954-017-0141-6. Harm Reduct J. 2017. PMID: 28431584 Free PMC article.
Late presentation of chronic viral hepatitis for medical care: a consensus definition.
Mauss S, Pol S, Buti M, Duffell E, Gore C, Lazarus JV, der Grient HL, Lundgren J, Mozalevskis A, Raben D, Schatz E, Wiktor S, Rockstroh JK; European consensus working group on late presentation for Viral Hepatitis Care. Mauss S, et al. Among authors: lazarus jv. BMC Med. 2017 May 3;15(1):92. doi: 10.1186/s12916-017-0856-y. BMC Med. 2017. PMID: 28464883 Free PMC article.
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe.
Marshall AD, Cunningham EB, Nielsen S, Aghemo A, Alho H, Backmund M, Bruggmann P, Dalgard O, Seguin-Devaux C, Flisiak R, Foster GR, Gheorghe L, Goldberg D, Goulis I, Hickman M, Hoffmann P, Jancorienė L, Jarcuska P, Kåberg M, Kostrikis LG, Makara M, Maimets M, Marinho RT, Matičič M, Norris S, Ólafsson S, Øvrehus A, Pawlotsky JM, Pocock J, Robaeys G, Roncero C, Simonova M, Sperl J, Tait M, Tolmane I, Tomaselli S, van der Valk M, Vince A, Dore GJ, Lazarus JV, Grebely J; International Network on Hepatitis in Substance Users (INHSU). Marshall AD, et al. Among authors: lazarus jv. Lancet Gastroenterol Hepatol. 2018 Feb;3(2):125-133. doi: 10.1016/S2468-1253(17)30284-4. Epub 2017 Oct 3. Lancet Gastroenterol Hepatol. 2018. PMID: 28986139
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Papatheodoridis GV, Hatzakis A, Cholongitas E, Baptista-Leite R, Baskozos I, Chhatwal J, Colombo M, Cortez-Pinto H, Craxi A, Goldberg D, Gore C, Kautz A, Lazarus JV, Mendão L, Peck-Radosavljevic M, Razavi H, Schatz E, Tözün N, van Damme P, Wedemeyer H, Yazdanpanah Y, Zuure F, Manns MP. Papatheodoridis GV, et al. Among authors: lazarus jv. J Viral Hepat. 2018 Mar;25 Suppl 1:6-17. doi: 10.1111/jvh.12875. J Viral Hepat. 2018. PMID: 29508946 Review.
Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
Lazarus JV, Stumo SR, Harris M, Hendrickx G, Hetherington KL, Maticic M, Jauffret-Roustide M, Tallada J, Simojoki K, Reic T, Safreed-Harmon K; Hep-CORE Study Group. Lazarus JV, et al. J Int AIDS Soc. 2018 Apr;21 Suppl 2(Suppl Suppl 2):e25052. doi: 10.1002/jia2.25052. J Int AIDS Soc. 2018. PMID: 29633562 Free PMC article.
389 results